Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CC-10004 (Apremilast) in Recalcitrant Prurigo Nodularis
NCT00869089Phase 2Completed
- Sponsor
- University Hospitals Cleveland Medical Center
- Start
- Sep 2008
- Primary completion
- Jan 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of apremilast in prurigo nodularis (PN), sponsored by University Hospitals Cleveland Medical Center. Started Sep 2008; status: completed.
02
Drugs
apremilast
03
Conditions
prurigo nodularis (PN)
Beyond the preview
Go deeper on NCT00869089.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00869089.